Brain surgery trial tests new drug to help stroke survivors move again
NCT ID NCT07318714
Summary
This is the first study in people to test a new drug called ASP2246. It aims to see if it is safe and can help improve movement in adults who still have trouble moving an arm or leg several months after a stroke. The drug is delivered directly into the damaged area of the brain during surgery, and researchers will carefully monitor participants for a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.